Olympus Corporation
【Olympus】 Executive Appointments and Organizational Strengthening | August 2026
Olympus to appoint Bryan Barry as Chief Quality Officer effective August 1, 2026. Mr. Barry brings over 40 years of experience in quality and regulatory compliance, driving improvements in quality systems and global regulatory response.
Key Figures
- New Chief Quality Officer: Bryan Barry
- Resigned Executive: Boris Schorknik
- Appointment Date: August 1, 2026
AI要約
Overview of Executive Appointments
Effective August 1, 2026, Olympus appointed Bryan Barry as the new Chief Quality Officer. As a result, the previous officer, Boris Schorknik, will resign, and leadership in global quality and regulatory compliance will be strengthened. Mr. Barry has over 40 years of experience in medical device regulation and quality and will engage with worldwide regulatory authorities including the FDA and advance quality management systems.
Future Organizational Structure and Corporate Strategy
Under the new structure, led by President and Representative Director Bob White, efforts will be made to strengthen quality and regulatory compliance. With Mr. Barry's appointment, the company aims to promote patient safety and foster a quality culture, enhancing global regulatory response capabilities. This strategic move will establish a foundation to support long-term growth investments and improve corporate value.
Olympus Corporation
Company overview · Stock price · Financial data · All IR
